Patents by Inventor Arda Shahinian

Arda Shahinian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Polypeptides Involved in Immune Response
    Publication number: 20140004129
    Abstract: Polypeptides which comprise a receptor-ligand pair involved in T-cell activation are disclosed. Nucleic acid molecules encoding the polypeptides, and vectors and host cells for expressing the polypeptides are also disclosed. The polypeptides, or agonists and antagonists thereof, are used to treat T-cell mediated disorders.
    Type: Application
    Filed: October 2, 2012
    Publication date: January 2, 2014
    Applicants: AMGEN CANADA INC., AMGEN INC.
    Inventors: Steven K Yoshinaga, Tak W. Mak, Arda Shahinian, Anna Trafuri Bladt, Giorgio Senaldi
  • Polypeptides involved in immune response
    Patent number: 8309083
    Abstract: Polypeptides which comprise a receptor-ligand pair involved in T-cell activation are disclosed. Nucleic acid molecules encoding the polypeptides, and vectors and host cells for expressing the polypeptides are also disclosed. The polypeptides, or agonists and antagonists thereof, are used to treat T-cell mediated disorders.
    Type: Grant
    Filed: April 2, 2010
    Date of Patent: November 13, 2012
    Assignees: Amgen, Inc., Amgen Canada Inc.
    Inventors: Steven K. Yoshinaga, Tak W. Mak, Arda Shahinian, Anna Tafuri Bladt, Giorgio Senaldi
  • POLYPEPTIDES INVOLVED IN IMMUNE RESPONSE
    Publication number: 20110059068
    Abstract: Polypeptides which comprise a receptor-ligand pair involved in T-cell activation are disclosed. Nucleic acid molecules encoding the polypeptides, and vectors and host cells for expressing the polypeptides are also disclosed. The polypeptides, or agonists and antagonists thereof, are used to treat T-cell mediated disorders.
    Type: Application
    Filed: April 2, 2010
    Publication date: March 10, 2011
    Inventors: STEVEN K. YOSHINAGA, TAK W. MAK, ARDA SHAHINIAN, ANNA TAFURI BLADT, GIORGIO SENALDI
  • Polypeptides involved in immune response
    Patent number: 7708993
    Abstract: Polypeptides which comprise a receptor-ligand pair involved in T-cell activation are disclosed. Nucleic acid molecules encoding the polypeptides, and vectors and host cells for expressing the polypeptides are also disclosed. The polypeptides, or agonists and antagonists thereof, are used to treat T-cell mediated disorders.
    Type: Grant
    Filed: February 21, 2006
    Date of Patent: May 4, 2010
    Assignee: Amgen Inc.
    Inventors: Steven K. Yoshinaga, Tak W. Mak, Arda Shahinian, Anna Tafuri Bladt, Giorgio Senaldi
  • Novel polypeptides involved in immune response
    Publication number: 20060140944
    Abstract: Novel polypeptides which comprise a receptor-ligand pair involved in T-cell activation are disclosed. Nucleic acid molecules encoding said polypeptides, and vectors and host cells for expressing same are also disclosed. The polypeptides, or agonists and antagonists thereof, are used to treat T-cell mediated disorders.
    Type: Application
    Filed: February 21, 2006
    Publication date: June 29, 2006
    Inventors: Steven Yoshinaga, Tak Mak, Arda Shahinian, Anna Bladt, Giorgio Senaldi